Business
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.
The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
The funds come two years after the company scored a $1.15 billion investment.
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.
The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.
President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.
Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.
Sehat Kahani is now exploring predictive AI in telehealth.
Also, Cipla has increased its stake in digital pharma solutions company GoApptiv.